Computer tomography-guided core biopsies in a county hospital in Sweden: Complication rate and diagnostic yield
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Medknow in Annals of Thoracic Medicine
- Vol. 9 (3) , 149-53
Abstract
Background: Core biopsies are valuable in obtaining sufficient tissue to ensure diagnosis of diseases in the thorax. Objective: To evaluate the complication rate and the diagnostic yield in computer tomography (CT)-guided core biopsies performed in a county hospital in Sweden. Methods: Medical journals, spirometry results, pathology reports and CT scans were reviewed in 463 consecutive cases, where a transthoracic core biopsy was performed between January 2005 and December 2010. Of these 380 (82%) were lung lesions, 48 (10%) were mediastinal lesions and 35 (8%) were pleural lesions. Results: All patients underwent a chest X-ray 4 hours post-biopsy and pneumothorax was seen in 156/463 (34%) patients: 137 after lung biopsy and 17 after mediastinal biopsy. Chest tube insertion was required for 27 (17%) of these patients (6% of all core biopsies). Small intraparenchymal hemorrhages and hemoptysis were observed with subjective difficulty in one case. The diagnostic yield for the 463 patients was 212 (46%) cases of lung cancer, 188 (41%) benign lesions and 39 (8%) pulmonary metastases. Conclusions: A transthoracic core biopsy ensures diagnosis with a low complication rate and is suitable as an outpatient procedure. An increased risk for pneumothorax was observed when the biopsied lesion was small or when emphysema was in the path of the biopsy needle. Reduced lung function pre-biopsy or emphysema in the path of the biopsy needle increased the need for chest tube treatment of pneumothorax. A CT-guided core biopsy is safe and applicable in a county hospital.Keywords
This publication has 23 references indexed in Scilit:
- Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Estimates of cancer incidence and mortality in Europe in 2008European Journal of Cancer, 2010
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKJournal of Clinical Oncology, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiLJournal of Clinical Oncology, 2009
- Computed Tomography–Navigated Transthoracic Core Biopsy of Pulmonary LesionsAcademic Radiology, 2008
- Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- The Myeloproliferative DisordersNew England Journal of Medicine, 2006
- CT-guided needle biopsy of lung lesions: A survey of severe complication based on 9783 biopsies in JapanEuropean Journal of Radiology, 2006
- CT-Guided Transthoracic Needle Biopsy of Pulmonary Nodules Smaller than 20 mm: Results with an Automated 20-Gauge Coaxial Cutting NeedleClinical Radiology, 2000